Roux, Lauriane N.

Modeling of Aniridia-Related Keratopathy by CRISPR/Cas9 Genome Editing of Human Limbal Epithelial Cells and Rescue by Recombinant PAX6 Protein

Roux, L. N., Petit, I., Domart, R., Concordet, J.-P., Qu, J., Zhou, H., Joliot, A., Ferrigno, O., & Aberdam, D. (2018) · Stem Cells

Corneal Surgery and TreatmentsOcular Disorders and Treatments

Cited by 56

Improvement of epidermal covering on AEC patients with severe skin erosions by PRIMA-1MET/APR-246

Aberdam, E., Roux, L. N., Secrétan, P.-H., Boralevi, F., Schlatter, J., Morice-Picard, F., Sol, S., Bodemer, C., Missero, C., Cisternino, S., et al. (2020) · Cell Death & Disease

Genetic and rare skin diseases.Skin and Cellular Biology Research

Cited by 26

The antipsychotropic drug Duloxetine rescues PAX6 haploinsufficiency of mutant limbal stem cells through inhibition of the MEK/ERK signaling pathway

Dorot, O., Roux, L. N., Zennaro, L., Oved, K., Bremond-Gignac, D., Pichinuk, E., & Aberdam, D. (2022) · The Ocular Surface

Ocular Disorders and TreatmentsCorneal Surgery and Treatments

Cited by 18

Ritanserin, a potent serotonin 2A receptor antagonist, represses MEK/ERK signalling pathway to restore PAX6 production and function in aniridia-like cellular model

Oved, K., Zennaro, L., Dorot, O., Zerbib, J., Frank, E., Roux, L. N., Bremond-Gignac, D., Pichinuk, E., & Aberdam, D. (2021) · Biochemical and Biophysical Research Communications

Ocular Disorders and TreatmentsCorneal Surgery and Treatments

Cited by 16